Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Sudip Bandyopadhyay reaffirms long-term bullish view on LIC
11/08/2025
Positive Breakout : Sanghvi Movers, Motherson Sumi among 10 stocks close cross above their 200 DMA
11/08/2025
BlueStone Jewellery IPO opens for subscription ; GMP at 2%. Check all details
11/08/2025
The Russian past of Alaska, where Trump and Putin will meet
11/08/2025
Trump wants to evict homeless from Washington and send them 'far from the capital'
11/08/2025
Foreign investors turn bearish on Indian stocks amid weakening rupee and tariffs
11/08/2025
